Literature DB >> 26401084

Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.

Wen-Hua Zhu1, Li-Zheng Fang1, Chong-Rong Lu1, Hong-Lei Dai1, Jian-Hua Chen1, Qiao-Hua Qiao1, Li-Ying Chen1.   

Abstract

AIM: To assess the relationship between non-alcoholic fatty liver disease (NAFLD) with metabolic risk factors and brachial ankle pulse wave velocity (baPWV).
METHODS: A total of 8603 subjects (6662 males and 1941 females) were enrolled during an annual health check-up. Fatty liver was examined using a Philips HD 11 XE multi-function color Doppler diagnostic instrument, and baPWV was determined using a novel arteriosclerosis detection device. Blood pressure (BP), fasting plasma glucose (FPG), waist circumference (WC), plasma triglycerides (TG), high-density lipoprotein (HDL), total cholesterol (TC), low-density lipoprotein (LDL) and uric acid (UA) were measured using standard methods. The relationship between fatty liver with metabolic risk factors and baPWV was analyzed using regression analysis and the χ (2) test.
RESULTS: The values and abnormal rates of baPWV were significantly different between NAFLD patients and non-NAFLD subjects (P < 0.001). In addition, the values of baPWV were different by gender between NAFLD patients and non-NAFLD subjects. The OR values in females, males, and the entire population were 3.33, 1.67, and 2.13, respectively (P < 0.001). The incidence of high baPWV increased with increasing degree of NAFLD (levels 0, 1, 2, and 3) (P < 0.001), which was 45.9%, 54.5%, 60.2%, and 71.4% in males and 27.0%, 49.1%, 55.60%, and 60.0% in females (P < 0.001), respectively. Logistic regression analysis showed that the OR value for baPWV in the non-metabolic syndrome group and the metabolic syndrome group was 1.28 vs 1.14 (males) and 2.55 vs 0.98 (females). The OR values for baPWV in the non-high-BP and high-BP, non-high-WC and high-WC, non-high-FPG and high-FPG, non-high-TG and high-TG, non-high-HDL and high-HDL, non-high-TC and high-TC, non-high-LDL and high-LDL, non-high-UA and high-UA groups were 3.38 vs 1.19, 3.50 vs 1.44, 2.80 vs 2.30, 3.29 vs 1.88, 3.03 vs 3.28, 3.35 vs 2.70, 3.93 vs 1.66, and 3.20 vs 2.34, respectively, in females (P < 0.001), and were 1.37 vs 1.34, 1.56 vs 1.26, 1.51 vs 1.28, 1.49 vs 1.52, 1.71 vs 1.61, 1.59 vs 1.74, 1.76 vs 1.47, and 1.73 vs 1.54, respectively, in males (P < 0.01). The OR value for baPWV was still higher than 1.2 (1.21 in males and 1.40 in females) after adjustment for the metabolic component (0, 1, 2, 3, 4, 5, 6 and above) (P < 0.01).
CONCLUSION: NAFLD is closely correlated with baPWV, particularly in females. NAFLD has a large impact on baPWV, no matter whether the metabolic index is increased or not. NAFLD may be a useful indicator for assessing early arteriosclerosis.

Entities:  

Keywords:  Brachial ankle pulse wave velocity; Metabolic risk factors; Non-alcoholic fatty liver

Mesh:

Substances:

Year:  2015        PMID: 26401084      PMCID: PMC4572800          DOI: 10.3748/wjg.v21.i35.10192

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition.

Authors:  Fan Jian-gao
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2010-03

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.

Authors:  Amélie Cartier; Isabelle Lemieux; Natalie Alméras; Angelo Tremblay; Jean Bergeron; Jean-Pierre Després
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

4.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

Authors:  Michael Miller; Neil J Stone; Christie Ballantyne; Vera Bittner; Michael H Criqui; Henry N Ginsberg; Anne Carol Goldberg; William James Howard; Marc S Jacobson; Penny M Kris-Etherton; Terry A Lennie; Moshe Levi; Theodore Mazzone; Subramanian Pennathur
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

Review 5.  [Role of sex hormones in nonalcoholic fatty liver disease pathogenesis].

Authors:  Ya-dong Wang; Ying-ze Zhang; Cai-yan Zhao; Wei Cao
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2012-05

6.  Long-term follow-up of patients with nonalcoholic fatty liver.

Authors:  Nila Rafiq; Chunhong Bai; Yun Fang; Manirath Srishord; Arthur McCullough; Terry Gramlich; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2008-11-07       Impact factor: 11.382

7.  Metabolic syndrome and gallstone disease.

Authors:  Li-Ying Chen; Qiao-Hua Qiao; Shan-Chun Zhang; Yu-Hao Chen; Guan-Qun Chao; Li-Zheng Fang
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

Review 8.  Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

Authors:  Fabio Marra; Amalia Gastaldelli; Gianluca Svegliati Baroni; Gianluca Tell; Claudio Tiribelli
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

9.  Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo O Castaño; Adriana L Burgueño; María Soledad Rosselli; Tomas Fernández Gianotti; Pablo Mallardi; Julio San Martino; Carlos Jose Pirola
Journal:  Atherosclerosis       Date:  2009-10-13       Impact factor: 5.162

10.  Right and left mesial temporal lobe seizures in one patient: bona fide semiological, interictal, ictal, and MRI evidence.

Authors:  Luciano De Paola; Carlos Silvado; Luciana Souza; Ana Crippa; Carlos Alexandre Twardowschy; Francisco Germiniani; Maria Joana Mäder; André Palmini
Journal:  Epilepsy Behav       Date:  2008-11-21       Impact factor: 2.937

View more
  2 in total

Review 1.  Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics.

Authors:  Guglielmo M Trovato
Journal:  World J Gastrointest Pathophysiol       Date:  2020-05-12

2.  Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.

Authors:  Jilin Zheng; Yong Zhou; Kuo Zhang; Yu Qi; Shimin An; Siyuan Wang; Xingquan Zhao; Yi-Da Tang
Journal:  BMC Cardiovasc Disord       Date:  2018-07-16       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.